negative growth stimuli or in their vulnerability to acquiring Switzerland mutations. In rodents, the liver was found to be particularly 2 To whom correspondence should be addressed sensitive towards non-genotoxic carcinogens (5). Therefore, Down-regulation of the mitogenic activity of the rodent liver we addressed the question whether cultured rat hepatocytes, carcinogen cyproterone acetate (CPA) and of epidermal stimulated by an exogenous or an endogenous mitogen, respond growth factor (EGF) were compared in cultured rat differentially to negative growth control initiated by transhepatocytes. Both hepatomitogens produce an increase in forming growth factor β1 (TGF-β1*). This was carried out the expression of proliferating cell nuclear antigen (PCNA) with two rodent liver mitogens, the carcinogenic and synthetic and in [ 3 H]thymidine incorporation in a dose-dependent steroid cyproterone acetate (CPA) and the endogenous peptide manner. In combination, the two mitogens induced an epidermal growth factor (EGF). additive mitogenic response. Concomitant exposure to the CPA is found in oral anti-acnegenic contraceptives and is growth inhibitory cytokine transforming growth factor β1 used to treat prostate carcinoma, male hypersexualism and (TGF-β1) resulted in a differential dose-dependent downsigns of androgenization in women. In a rat liver foci bioassay, regulation of PCNA-expressing cells. The correspond-CPA induced altered foci in female rats (6) but not in male ing down-regulation of CPA-induced PCNA expression rats (7). At lower doses CPA increased benign liver proliferation required a 3-to 5-fold higher TGF-β1 concentration than (8) and at higher levels hepatic tumours in rats and mice, both for EGF-induced expression. In contrast, CPA-exposed males and females (9). The mitogenic activity of CPA in rat hepatocytes become vulnerable to and EGF-exposed cells liver was demonstrated in vivo (10) and in vitro (11), whereas protected against the apoptosis-inducing activity of TGFin human hepatocytes the mitotic activity was found only in β1 (Ͼ0
sensitive towards non-genotoxic carcinogens (5) . Therefore, Down-regulation of the mitogenic activity of the rodent liver we addressed the question whether cultured rat hepatocytes, carcinogen cyproterone acetate (CPA) and of epidermal stimulated by an exogenous or an endogenous mitogen, respond growth factor (EGF) were compared in cultured rat differentially to negative growth control initiated by transhepatocytes. Both hepatomitogens produce an increase in forming growth factor β1 (TGF-β1*). This was carried out the expression of proliferating cell nuclear antigen (PCNA) with two rodent liver mitogens, the carcinogenic and synthetic and in [ 3 H]thymidine incorporation in a dose-dependent steroid cyproterone acetate (CPA) and the endogenous peptide manner. In combination, the two mitogens induced an epidermal growth factor (EGF). additive mitogenic response. Concomitant exposure to the CPA is found in oral anti-acnegenic contraceptives and is growth inhibitory cytokine transforming growth factor β1 used to treat prostate carcinoma, male hypersexualism and (TGF-β1) resulted in a differential dose-dependent downsigns of androgenization in women. In a rat liver foci bioassay, regulation of PCNA-expressing cells. The correspond-CPA induced altered foci in female rats (6) but not in male ing down-regulation of CPA-induced PCNA expression rats (7) . At lower doses CPA increased benign liver proliferation required a 3-to 5-fold higher TGF-β1 concentration than (8) and at higher levels hepatic tumours in rats and mice, both for EGF-induced expression. In contrast, CPA-exposed males and females (9) . The mitogenic activity of CPA in rat hepatocytes become vulnerable to and EGF-exposed cells liver was demonstrated in vivo (10) and in vitro (11) , whereas protected against the apoptosis-inducing activity of TGFin human hepatocytes the mitotic activity was found only in β1 (Ͼ0.1 ng/ml). Under culture conditions that mimicked the presence of growth factors (12) . The synthetic steroid a pericentral-equivalent microenvironment (low oxygen exerted no mutagenic activity in tests with bacteria and tension, low glucagon concentration), PCNA expression mammalian cells (13, 14) , but recent findings demonstrated an was 3-fold lower and CPA-specific resistance was no longer induction of DNA repair synthesis (15, 16) . Reports about its detectable. It is concluded that EGF and CPA induce their clastogenic activity in hepatocytes were inconclusive (17) . growth stimuli preferentially in the periportal area of the Highly persistent DNA adducts of the metabolite 3α-hydroxyliver but in different hepatocyte sub-populations, which cyproterone acetate were found (18, 19) , particularly in female differ in their down-regulation of premitotic events by rat liver (20) . Together, the data imply that CPA is a complete TGF-β1. At low TGF-β1 concentrations, EGF-stimulated carcinogen in female rodent liver at high doses, whereas in cells shift back into a resting cell cycle phase, whereas male liver it is predominantly the mitogenic stimulus that CPA-treated hepatocytes are eliminated by apoptosis at contributes to tumourigenesis. higher TGF-β1 concentrations.
Negative growth control in hepatocytes can be initiated by low levels of TGF-β1 (21) . This cytokine is a potent inhibitor of cell growth in parenchymal liver cells as well as Introduction in rat and human hepatocytes (22, 23) . In addition, TGF-β1 is Cell proliferation is an important promoting factor in tumour one of the most effective endogenous growth inhibitors after induction and progression in rodents (1, 2) . Chemically induced partial hepatectomy (24). It is expressed in most liver cells, cell cycle progression can be stimulated directly by interactions including hepatocytes (25), and acts via paracrine and autocrine with growth stimulating factors (3) or indirectly by regenerative mechanisms. growth as a consequence of chemically induced cell necrosis
In order to obtain in vitro information which adequately (4) .
represents the situation in liver, cultured hepatocytes should Endogenously controlled high rates of cell proliferation are be growth arrested and should preserve or re-acquire tissuewell tolerated in many tissues, whereas exogenous chemicals equivalent metabolic competence. This was achieved by the that induce a mitogenic stimuli often act as non-genotoxic use of a tissue-specific extracellular matrix (26, 27) 
Apoptotic events

Materials and methods
Apoptotic cells (condensed and fragmented nuclei) were identified 48 h after Chemicals and biologicals the beginning of treatment in Hoechst dye 33Ј342 stained hepatocytes as Chemicals and biochemicals were of reagent grade and purchased from reported earlier (30). Cells with condensed nuclei were rarely seen. A Sigma (St Louis, MO). Cell culture products were purchased from Gibco fragmented nucleus was defined as (i) one or more brightly fluorescent (Paisley, UK) and from Seromed (Berlin, Germany). Porcine collagen type I (condensed) chromatin pieces within an area equivalent to a nucleus surrounded was from Pentapharm (Basel, Switzerland). Human recombinant TGF-β1 was by cytoplasmic material (apoptotic bodies) or (ii) a cluster of chromatin pieces a generous gift of Dr K.Frei (Institute for Clinical Immunology, University within a cell without a nucleus. Hospital of the University of Zurich, Switzerland). Human recombinant EGF Data analysis was purchased from Becton Dickinson (Bedford, MA).
The mean value and the standard error of the mean (SEM) were calculated Antibodies were purchased from the following sources: monoclonal mouse for each parameter measured. Significance of differences between means was anti-proliferating cell nuclear antigen (PCNA) antibody (PC-10) from DAKO calculated using Student's t-test for paired or unpaired samples as appropriate. (Glostrup, Denmark); Cy3™-conjugated AffiniPure F(ab') 2 fragment goat
The level of significance chosen was P Ͻ 0.05. 48 h was effective in a similar way.
In all the experiments the medium was changed 4 and 20 h after seeding and CPA and EGF increase PCNA expression and DNA synthesis then daily. After 2 days in culture, hepatocytes were exposed to the mitogens and/or to TGF-β1 for 48 h. Stock solutions of CPA were freshly prepared in incorporation (15 h pulse) by low and high levels of TGF-β1. CPA or EGF (A) and EGFϩCPA-induced PCNA expression (B) by TGF-β1 (mean of were administred together with TGF-β1 from days 2-4 in culture. Mean of three independent experiments Ϯ SD). CPA or EGF were administred three independent experiments Ϯ SD. together with TGF-β1 from days 3-4 in culture. PCNA-positive nuclei were counted with a microscope as described in Materials and methods. 33Ј342 stained nuclei (30). After exposure to 1 ng/ml TGF-β1, the CPA-exposed hepatocytes showed a 3-fold higher incidence When exposed to 0.1 ng/ml TGF-β1, the relative inhibition of fragmented nuclei ( Figure 4A ) and the EGF-exposed cells a of PCNA nuclei was the same in control cells as in those 50% lower incidence ( Figure 4B ) than cells treated with TGFtreated with 1 or 10 ng/ml EGF, namely~40% (Figure 2A) . β1 alone. CPA and EGF alone had no effect on the spontaneous In contrast, at this low TGF-β1 dose 3 µM and 12 µM CPAlevel of apoptotic cells. In cells exposed concomitantly to EGF treated cells showed a further stimulation of PCNA nuclei and CPA the higher sensitivity to TGF-β1-induced apoptotic (20 and 10% respectively). At a higher dose of TGF-β1 processes was abolished ( Figure 4B ). (0.5 ng/ml) all cells showed inhibition of PCNA expression, LDH release after 48 h exposure to TGF-β1, in combination but much more pronounced in EGF-treated, in EGFϩCPA-with aberrant nuclei, reflects the late phase of apoptotic cells treated or in control cells (60-80% inhibition) than in CPA-(30). Extracellular LDH activity was not significantly increased exposed cells (35%) ( Figure 2B) . after exposure to the mitogens ( Figure 5 ). With increasing TGF-[ 3 H]TdR incorporation was not differentially affected: both β1 concentration, in parallel with the incidence of fragmented CPA-and EGF-induced [ 3 H]TdR incorporation was reduced nuclei, extracellular LDH activity increased; it was higher in the by one third at 0.1 ng/ml and returned to control levels at CPA-( Figure 5A ) and lower in the EGF-exposed hepatocytes 1 ng/ml TGF-β1. In untreated hepatocytes, after exposure to ( Figure 5B) than in the corresponding cultures without mitogen 0.1 ng/ml TGF-β1 [ 3 H]TdR incorporation was doubled, but treatment. the difference was not significant (Figure 3) .
Differential inhibitory activity of TGF-β1 on PCNA expression Differential susceptibility of CPA-and EGF-exposed cells is abolished in a pericentral equivalent microenvironment towards TGF-β1-induced apoptosis
The experimental conditions used in the experiments described Exposure of hepatocytes to TGF-β1 concentrations Ͼ0.1 ng/ml resulted in a dose-dependent increase in apoptotic nuclei (Figure thus far (24-well cultures, under air, 10 nM glucagon) approxi-of CPA-stimulated hepatocytes to down-regulation by low levels of TGF-β1.
Discussion
Investigations on growth stimuli or impaired negative growth control in cell cultures might be greatly affected by the proliferative capacity and the metabolic state of the cells. In the present study, at the beginning of the exposure to the mitogens the hepatocytes expressed liver-specific functions (28,29) and a low spontaneous mitogenic activity comparable with that found in the intact organ.
Negative growth control and liver-specific metabolism after partial hepatectomy are induced in hepatocytes (37). This entry into the cell cycle after liver perfusion might be the reason for the initially high levels of PCNA expression in our hepatocytes. However, only a small proportion of these PCNApositive cells enter S phase, as indicated by the only slightly increased DNA synthesis rate within 48 h after seeding. Thus, enzymic dissociation shifts hepatocytes from G 0 into middle to late G 1 , but not into S phase. Accordingly, the majority of PCNA-expressing hepatocytes in our cultures represent cells arrested in mid to late G 1 phase (38).
The efficient spontaneous down-regulation of this 'compensatory' growth stimulus within 2 days in our cultures is most likely the consequence of the high cell density (downregulation of immediate early genes; 39,40) and the culture conditions chosen. Expression of liver-specific metabolism seems to be linked to active negative growth control. This is concluded from the fact that the loss of P450 mRNAs after hepatocyte isolation parallels an increase in proliferative activity (37) and an increase in xenobiotic metabolism after 2-7 days in culture (41) parallels the decrease in PCNA expression.
Mitogenic effects of EGF and CPA
The present experiments demonstrate that EGF and CPA shift quiescent hepatocytes with well-preserved liver-specific functions (29,41) into G 1 and some into S phase. No serum, and in the case of CPA no co-administration of EGF, was required, in contrast to a previous report (42) , in which PCNA metabolic activation (20) , most likely via a hydroxysteroid sulfotransferase (44) . Whether metabolic activation is also required for the mitogenic activity of CPA remains to be mate periportal conditions (36). Pericentral-equivalent cultures (PC cultures) can be mimicked by culturing cells at low glucagon elucidated. Effective CPA concentrations in our in vitro investigaconcentrations (1 nM) and low oxygen tension. This can be achieved by the use of Teflon membrane culture dishes kept at tions are in the range of those found in the serum of rats treated with the synthetic hormone (45) . It is noteworthy that 4% O 2 (28). As a corresponding reference, hepatocytes were cultured in parallel in Teflon membrane culture dishes under PCNA expression plateaus at CPA concentrations which induce maximal DNA synthesis and remains at higher concentrations 13% O 2 in the same medium as used in the 24-well dishes (PP cultures). The oxygen tension is then comparable to that under air where DNA synthesis is inhibited. Clearly, only a limited number of hepatocytes are able to respond to the mitogenic in conventional culture dishes. Accordingly, differential downregulation was again detectable (Figure 6 ). However, two findstimulus of CPA. The additive, partially synergistic response after combined treatment with CPA and EGF ( Figure 1B ) ings differed in PC cultures ( Figure 6 ): (i) EGF and CPA were both much less effective (EGF 1/2 and CPA 1/4 of 'periportal'
indicates that CPA stimulates additional cells that are not responding to EGF. A similar additive response was reported values); (ii) CPA-stimulated hepatocytes lost their resistance to 0.1 ng/ml TGF-β1. The metabolic status of the hepatocytes, for the induction of DNA synthesis (12) . The two mitogens therefore act via different pathways and as a consequence which is differentially affected by the two culture conditions (28), seems to affect the mitogenic response and the resistance affect different cell populations.
The differential mitoinhibitory activity of TGF-β1
of TGF-β1 and by that they become resistant to apoptosisinducing levels of TGF-β1. In contrast, CPA-stimulated hepato-TGF-β1 is a key factor in pre-replicative negative growth cytes cannot re-enter the resting cell cycle phase initiated by control. After partial hepatectomy, TGF-β1 mRNA is increased low levels of TGF-β1, but become a target for higher TGFin non-parenchymal liver cells before the major wave of β1 levels and escape via apoptosis. In favour of the second DNA synthesis has been initiated (46) . Accordingly, the interpretation are the additive/synergistic induction of PCNAmitoinhibitory activity of TGF-β1 acts in cells at or prior to expressing cells (Figure1B), the fraction of cells responding the G 1 /S cell cycle phase transition (47) .
to 0.1 ng/ml TGF-β1 after combined exposure to CPA and Normal hepatocytes release TGF-β by an autocrine EGF ( Figure 2A ) and, as discussed in the following section, mechanism in its latent form (25) and are unable to activate the influence of an altered metabolism as induced under PC TGF-β complexes in vitro (24). This and the dose-response culture conditions. relationship seen in our study confirms that the added activated
Regiospecific response recombinant TGF-β1 antagonizes endogenous and exogeneous growth signals in rat hepatocytes. The TGF-β1 concentrations Theoretically, liver lobules can be divided into a proliferative/ used were physiologically relevant. For the corresponding mitogenic (periportal) and a functional/apoptotic (pericentral) down-regulation of CPA-exposed cells a 3-(IC 50 ) to 5-fold compartment (50) (51) (52) . Hepatocyte cell populations within liver (IC 5 ) higher TGF-β1 concentration is required when compared lobule regions might differ in their degree of differentiation with EGF-stimulated cells (Figure 1 ). This differential downand their metabolic competence. Reduction of glucagon conregulation can be observed at low or high concentrations of centration and of oxygen tension shift cellular metabolism the two mitogens ( Figure 2A ). This demonstrates that the towards that described for the pericentral region (28). The resistance is related to the type of mitogen and not to the reduced activity of the two mitogens and the loss of resistance intensity of the mitogenic response. The absence of a differento low levels of TGF-β1 in PC cultures ( Figure 6 ) correspond tial response in cells that enter DNA synthesis ( Figure 3) well with the reported increased sensitivity to TGF-β1 under suggests that down-regulation of PCNA expression occurs these culture conditions (30). It also corresponds well with prior to the G 1 /S phase transition.
in vivo studies in which the mitotic activity of EGF (53) and of CPA (8, 54) was mainly found in the periportal area, Down-regulation of CPA-stimulated hepatocytes via an including down-regulation by apoptosis after withdrawal of apoptotic pathway CPA (54) . The present in vitro findings support data from an It is well established that high levels of TGF-β1 induce animal study in which apoptosis induced by CPA withdrawal apoptosis in vivo (48) and in vitro (30, 49) . This was also did not occur in DNA synthesizing cells (54) . found in our study at 48 h culture time at concentrations above The loss of the differential response in PC cultures can be 0.1 ng/ml TGF-β1. The differential dose-dependent increase attributed either to low glucagon concentrations or low oxygen in fragmented nuclei ( Figure 4A ) and LDH release ( Figure 5A tension. The interaction of glucagon with mitogenic processes and B) indicate that CPA-treated hepatocytes are sensitized to is controversial and seems to depend on the exposure levels and EGF-treated ones protected against the apoptotic activity and cell density chosen. High levels of glucagon (10 nM), as of TGF-β1. The differential down-regulation can also be seen used in our 24-well or PP cultures, might even be mitoinhibitory at higher TGF-β1 levels ( Figure 4B ). In EGF-exposed cells (55) . No interaction was detectable between TGF-β1 and the IC 50 (0.124 ng/ml) of TGF-β1 for PCNA downglucagon in rat hepatocyte cultures (47) . However, glucagon regulation induced no apoptosis, whereas the IC 50 for CPA concentrations chosen affect basal metabolism in the hepato-(0.305 ng/ml) significantly increased the number of fragcytes (28) and low oxygen tension, as reported earlier (56, 57) , mented nuclei ( Figure 4A ). This fits well with an in vitro study modulates chemically induced growth stimuli. in which CPA increased the apoptotic activity of TGF-β1 in
In conclusion, the experiments demonstrate differences cultured rat hepatocytes (42) . The protective effect of EGF is between the down-regulation of an endogenous (EGF) and an stronger than the apoptotic stimulus of CPA, as indicated by exogenous (CPA) mitogenic stimulus by TGF-β1. The exposure the additive response after simultaneous exposure to CPA levels of the growth inhibitory cytokine and the metabolic and EGF ( Figure 4B ). This indicates that the EGF-mediated state of the cultured hepatocytes are crucial. It seems that protection against apoptosis precedes sensitization and is also endogenous and exogenous growth stimuli affect different effective in CPA-stimulated hepatocytes.
hepatocyte populations. CPA-stimulated cells are less Taken together, the results suggest that EGF-stimulated susceptible to down-regulation by low levels of TGF-β1 PCNA-expressing hepatocytes are down-regulated by a shift than are EGF-exposed cells. Down-regulation in CPA-exposed from a prereplicative into a resting cell cycle phase, whereas hepatocytes, in contrast to EGF-exposed hepatocytes, occurs CPA-stimulated cells are more resistant to this pathway and preferentially via apoptosis inducible at higher TGF-β1 levels. are eliminated by apoptosis. Two different modes of action Therefore, at low (e.g. tissue equivalent) TGF-β1 levels, CPAare possible. Firstly, EGF-exposed hepatocytes are arrested in stimulated hepatocytes have less chance of re-entering the mid to late G 1 phase and thus are sensitive to the mitoinhibitory resting cell cycle phase compared with EGF-stimulated cells activity of low levels of TGF-β1, whereas CPA-exposed and have a higher risk of acquiring and fixing a spontaneous hepatocytes proceed further into the cell cycle (e.g. late G 1 premutagenic lesion into a mutation which could contribute to phase), at which point they lose their responsiveness to low tumour formation. levels of TGF-β1 but become more vulnerable to the apoptosisinducing signal at higher concentrations. Alternatively, EGF
